Vascular News and Research

RSS

New phone number to University of Michigan memory loss and dementia services

Her diagnosis was scary: Alzheimer's Disease. So Myriam Torres was desperate for accurate information and help with coping with what the future might bring.

23 Feb 2012

Surgery associated with brain atrophy in elderly patients with MCI

A study published in the March issue of Anesthesiology found that elderly patients with mild cognitive impairment (MCI), as well as normal elderly undergoing surgery experienced increased levels of brain atrophy beyond what is expected from normal aging.

23 Feb 2012

First molecular evidence links body's natural circadian rhythms to SCD

A fundamental discovery reported in the March 1st issue of the journal Nature, uncovers the first molecular evidence linking the body's natural circadian rhythms to sudden cardiac death (SCD). Ventricular arrhythmias, or abnormal heart rhythms, are the most common cause of sudden cardiac death: the primary cause of death from heart disease.

23 Feb 2012

Volcano fourth quarter revenues increase 14% to $92.7 million

Volcano Corporation, a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today said revenues in the fourth quarter of 2011 increased 14 percent versus the fourth quarter of 2010.

23 Feb 2012

UMC Utrecht, DSM collaborate for Dyneema Purity fiber technology

DSM, a global leader in biomedical materials sciences, and University Medical Center Utrecht, a leading academic hospital with a renowned experimental facility unit for cardiothoracic interventions today announced that they have entered into a collaboration agreement.

22 Feb 2012

Screening events to find out risk for heart attack or stroke

If you could find out if you had an increased risk of heart attack or stroke, wouldn't you want to know? Even if you are fit and healthy, coronary artery disease (CAD) or peripheral artery disease (PAD) are conditions with little to no symptoms and can put you at an increased risk of heart attack or stroke.

20 Feb 2012

ETView Medical enters into patent license agreement for thoracic surgery devices

ETView Medical Ltd. announced today that it has entered into an exclusive license agreement for 2 US patents with James S. Simon, M.D., of Tiburon, California. The licensed patents are U.S. Pat. No. 7,052,456, entitled "Airway products having LEDs", and U.S. Pat. No. 6,189,533, entitled "Endotracheal Intubation Device".

20 Feb 2012

Low dose carbon monoxide therapy can prevent fetal death

Heme oxygenase-1 is essential for the growth of blood vessels in the placenta and in establishing blood flow in the umbilical cord. Too little HO-1 can lead to a restriction in the growth of the fetus and even in fetal death and miscarriage. New research published in BioMed Central's open access journal Medical Gas Research has shown that low dose carbon monoxide therapy is able to restore placental function and prevent fetal death in mice, without any detrimental effects.

19 Feb 2012

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.

From Medtronic 17 Feb 2012

Stent-assisted coil embolization helps repair coronary aneurysm

Methodist DeBakey Heart & Vascular Center interventional cardiologists have, for the first time, repaired a large coronary artery aneurysm with stent-assisted coil embolization without doing open heart surgery.

17 Feb 2012

Thrombocytosis linked to severity of ovarian cancer

Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine.

16 Feb 2012

Scott & White earns Joint Commission's certification for VAD Program

The Scott & White Heart & Vascular Institute in Temple has earned The Joint Commission's Gold Seal of Approval- as a hospital performing Ventricular Assist Device (VAD) as a destination therapy.

15 Feb 2012

Tetrahydrobiopterin plays a key role in arterial health of women

Researchers studying why arteries stiffen in postmenopausal women have found a specific chemical cofactor that dramatically improves vascular function.

15 Feb 2012

Scientists identify and describe molecular mechanism behind holoprosencephaly

Researchers of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch have now identified and described a molecular mechanism underlying the most common malformation of the brain in humans. In holoprosencephaly (HPE), the forebrain (prosencephalon) is only incompletely formed.

14 Feb 2012

Healthy, loving relationship is good for the heart

Being involved in a healthy, loving relationship is good for the heart, says Vanderbilt Heart and Vascular Institute cardiologist Julie Damp, M.D.

14 Feb 2012

UMDNJ-RWJMS, RWJUH among the first to offer TAVR procedure

Physicians at Robert Wood Johnson University Hospital (RWJ) and UMDNJ-Robert Wood Johnson Medical School (RWJMS) are among the first in the nation to offer a groundbreaking aortic valve replacement technique that provides new treatment options and hope for patients diagnosed with severe aortic valve disease who are suffering from end-stage heart disease.

14 Feb 2012

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron Pharmaceuticals, Inc. announced financial and operating results for the fourth quarter and full year 2011 and provided an update on development programs.

13 Feb 2012

KSU, St. Michael's receive U.S. patent to use BRCA1 gene for cardiovascular disease

St. Michael's Hospital and King Saud University have received their first joint U.S. patent to use the BRCA1 gene as a therapy for cardiovascular disease.

13 Feb 2012

Primary nitinol stent implantation effective in treating atherosclerosis than balloon angioplasty

A three-year follow-up study has shown that an alternate treatment for obstructed arteries in the leg may be warranted. The results are from a clinical trial comparing primary nitinol stent implantation with balloon angioplasty. This examination of the study provides a long-term assessment of the two procedures, which is favorable for the primary stent.

9 Feb 2012

First sign of coronary heart disease in men could be death

The healthy heart movement in recent years has focused largely on heart disease as the No. 1 killer of women. But the same statistic is true for men, and the reality is grim: The first sign that a man has coronary heart disease could be death, says one University of Alabama at Birmingham expert.

8 Feb 2012